Trial intelligence / Profile preview

Baofukang Shuan for bacterial vaginosis (Phase II, single-blind, randomized)

CTR20240497Phase 2Completed

Sponsor
Hainan Bikang Pharmaceutical
Start
Feb 2024
Modality
Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

A Phase 2 trial of baofukang shuan in bacterial vaginosis (BV), sponsored by Hainan Bikang Pharmaceutical. Started Feb 2024; status: completed.

02

Drugs

baofukang shuan
03

Conditions

bacterial vaginosis (BV)

Beyond the preview

Go deeper on CTR20240497.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20240497.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call